Zhong Ji Longevity Science Bolsters Board Independence With New Director Appointment

Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has issued an announcement.

Zhong Ji Longevity Science Group Limited has strengthened its board by appointing Ms. Tam Mei Chu as an independent non-executive director, effective 10 February 2026. The move underscores the company’s focus on enhancing governance and regulatory compliance as it refines its oversight structure.

Ms. Tam, a Hong Kong-based certified public accountant with extensive audit and company secretarial experience, will also join the audit, remuneration, nomination, risk management and share award committees. Her multiple roles across other Hong Kong-listed companies are expected to bolster the group’s board independence and ensure compliance with relevant listing rules, which may reassure investors and other stakeholders.

The most recent analyst rating on (HK:0767) stock is a Sell with a HK$0.47 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.

More about Zhong Ji Longevity Science Group Limited

Zhong Ji Longevity Science Group Limited is a Bermuda-incorporated company listed on the Hong Kong Stock Exchange. The group operates in the broader longevity and health-related sector, though this announcement focuses primarily on its corporate governance and board composition rather than specific products or services.

Average Trading Volume: 481,025

Technical Sentiment Signal: Sell

Current Market Cap: HK$302.4M

For a thorough assessment of 0767 stock, go to TipRanks’ Stock Analysis page.